Latest News
Feature
Medicaid reform: Work-based waivers may not fly
High mandatory premiums, cost sharing, lifetime limits, drug testing move Medicaid from a health care program to a work program, advocates argue...
Feature
CMS market stabilization efforts useless without subsidies
President Trump has threatened to withhold insurer subsidies in an effort to bring Congressional Democrats to the health care negotiation table....
Conference Coverage
MedPAC: Medicare Part B drug payment cuts, shared savings could save $5 billion
Reducing the amount physicians are paid for drugs administered in their offices and introducing shared savings could save Medicare up to $5...
From the Journals
Lifetime headache, suicide attempts may be linked in older patients
In elderly patients, an association is found between a risk of lifetime headache and lifetime suicide attempts.
Conference Coverage
Evidence for medical marijuana largely up in smoke
SAN DIEGO – Despite the popularity of medical marijuana, robust evidence for its use is limited or nonexistent for most medical conditions.
FDA/CDC
FDA approves first home genetic health risk test
Consumers do seem to want to know.
Commentary
Stroke hospitals owe all patients rapid thrombolysis
A high level of thrombolysis treatment is possible. It just isn’t being done everywhere.
Conference Coverage
New-onset AF boosts bad HFrEF outcomes
WASHINGTON – Monitor patients with heart failure with reduced ejection fraction for atrial fibrillation.
FDA/CDC
FDA approves deutetrabenazine for Huntington’s-associated chorea
Deutetrabenazine is only the second product approved to treat Huntington’s in any capacity, and it is the first in nearly a decade.
Conference Coverage
Hard road disproving that statins make you dumb
Do statins adversely affect mental health? The short answer is “no.”
Conference Coverage
Strontium, ketamine target troublesome itch
Topical formulations that contain ingredients such as ketamine and strontium have shown promise in alleviating severe itch in recent studies.